|
Outcomes
|
sST2 level
|
|---|
|
< 19 ng/ml
|
≥ 19 ng/ml
|
P trend
|
|---|
|
Primary outcome: MACEs
|
775
|
|
Number of cases (%)
|
321 (17.66)
|
454 (24.90)
|
< 0.001
|
|
Model 2 HR
|
1.00 (REF)
|
1.36 (1.17–1.56)
|
< 0.001
|
|
Cardiac death
|
163
|
|
Number of cases (%)
|
48 (2.64)
|
115 (6.31)
|
< 0.001
|
|
Model 2 HR
|
1.00 (REF)
|
1.70 (1.50–1.98)
|
0.033
|
|
MI
|
57
|
|
Number of cases (%)
|
21 (1.1)
|
36 (1.8)
|
0.066
|
|
Model 2 HR
|
REF
|
1.17 (0.67–2.04)
|
0.579
|
|
Unstable angina
|
550
|
|
Number of cases (%)
|
245 (13.48)
|
305 (16.73)
|
0.280
|
|
Model 2 HR
|
REF
|
1.42 (1.25–1.98)
|
< 0.001
|
|
Revascularization treatment
|
5
|
|
Number of cases (%)
|
2 (0.11)
|
3 (0.16)
|
0.343
|
|
Model 2 HR
|
REF
|
1.08 (0.94–1.17)
|
0.265
|
|
Secondary outcome: all-cause death
|
275
|
|
Number of cases (%)
|
90 (4.95)
|
185 (10.15)
|
< 0.001
|
|
Model 2 HR
|
1.00 (REF)
|
2.01 (1.56–2.59)
|
< 0.001
|
